Stage
Acquired | AcquiredAbout BioFactor Therapeutics
Developer of novel pharmaceutical approaches for the treatment of gastrointestinal disorders. The company's research is currently focussed around a proprietary bioactive peptide that has demonstrated antisecretory effects in animals and human healthy volunteers.
BioFactor Therapeutics Frequently Asked Questions (FAQ)
Where is BioFactor Therapeutics's headquarters?
BioFactor Therapeutics's headquarters is located at Stockholm.
What is BioFactor Therapeutics's latest funding round?
BioFactor Therapeutics's latest funding round is Acquired.
Who are the investors of BioFactor Therapeutics?
Investors of BioFactor Therapeutics include Melacure and HealthCap.